NCT04991181View on ClinicalTrials.gov

Absorption, Distribution, Metabolism and Excretion of BIA 5-1058

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

May 24, 2017

Study Completion Date

May 24, 2017

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

400 mg BIA 5-1058

Capsules, oral administered to subjects between 08:00 and 09:00 hours in the morning of Day 1after an overnight fast of at least 10 hours. The study drug was swallowed together with 240 mL tap water (room temperature).

Trial Locations (1)

9728 NZ

PRA Health Sciences (PRA) - Early Development Services (EDS), Groningen

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT04991181 - Absorption, Distribution, Metabolism and Excretion of BIA 5-1058 | Biotech Hunter | Biotech Hunter